ESAB’s (NYSE:ESAB) Q2 CY2026 Sales Beat Estimates

ESAB (NYSE:ESAB) reported Q2 CY2026 revenue of $807.6 million, up 12.9% year over year, exceeding Wall Street estimates by 2.6%. Non-GAAP EPS was $1.33, down from $1.36 a year earlier and 3% below consensus. Operating margin fell to 9.7% from the prior year. Analysts expect full-year EPS to rise from $5.31 to $6.08.

Original reporting
Published Aug 6, 2026, 2:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 3:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ESAB’s (NYSE:ESAB) Q2 CY2026 Sales Beat Estimates — source image
Decision brief

The 30-second read

$ESABNeutralMed
01

Why it matters

Traders may reprice ESAB based on the combination of a revenue beat, an adjusted EPS miss, and a sharp year-over-year operating margin decline, while also weighing the forward EPS growth expectation.

02

Market read

This is a mixed earnings update: top-line outperformance versus profitability and EPS underperformance, with forward EPS growth cited as a potential offset.

03

What to watch

Organic revenue was flat over two years, implying the headline growth may be supported by acquisitions/FX rather than underlying demand strength.

Relevance 7/10Novelty 7/10Timing: post-Q2 release, same-day reaction described

Background

ESAB is a welding and cutting equipment manufacturer, and the article frames its Q2 CY2026 results versus revenue and EPS expectations.

Company-level read

Ticker impact

$ESABNeutralMedium confidence
Context

ESAB reported Q2 CY2026 revenue of $807.6M, up 12.9% YoY, beating Wall Street estimates by 2.6%.

Expected impact

Likely supports the stock on revenue momentum, but margin/EPS weakness may cap upside and keep traders focused on forward EPS growth.

Evidence & confidence

The article cites a revenue beat (+12.9% YoY, +2.6% vs estimates) alongside adjusted EPS of $1.33 missing consensus and operating margin falling to 9.7% from the prior year.

Market effects

Signals demand may be stabilizing enough for revenue growth, but profitability leverage is not yet improving for industrial welding/cutting equipment.

No explicit regional demand or FX/geography breakdown provided.

No explicit global macro or supply-chain shock details beyond organic revenue being flat.

Counterpoint

The revenue beat plus expected full-year EPS growth (+14.6%) could outweigh the margin drop if costs normalize in coming quarters.

Key entities

  • ESAB

    Reported Q2 CY2026 revenue beat, adjusted EPS miss, and operating margin decline; provided forward-looking EPS growth expectation.

Related articles

$ESABMedAI 8/10

ESAB (ESAB) Q2 2026 Earnings Call Transcript

ESAB (ESAB) reported Q2 2026 core sales of $766 million, up 13% year over year, with 2.5% core organic growth. Adjusted EBITDA was $150 million, up 8%, and margin was 19.5%. Full-year guidance: core sales $3.0-$3.1B, adjusted EBITDA $615-$625M, adjusted EPS $5.40-$5.50, including Eddyfi. Middle East sales fell 10%-11% amid conflict.

$INFYMed

Aug 12: Markets Extend Losses as Tata Stocks, IT Shares Drag; Nifty Slips Below 24,450 – The Indian Awaaz

Indian benchmarks extended losses. The Nifty 50 fell 35.75 points, or 0.15%, to 24,435.95, and the Sensex dropped 187.90 points, or 0.24%, to 77,966.35. Tata stocks and IT shares weighed after Tata Sons chairman N Chandrasekaran said he will not seek reappointment. TCS fell 3.93% and Infosys 1.23%. India CPI inflation rose to 4.45% in July, from 4.38% in June.

$ESABMedAI 8/10

ESAB Q2 Deep Dive: Equipment Strength and Eddyfi Integration Drive Strategic Shift

ESAB reported Q2 revenue of $807.6 million, above analysts’ $787.2 million, with adjusted EPS of $1.33 versus $1.37 expected. Adjusted EBITDA was $151.4 million, slightly above estimates. Full-year adjusted EPS guidance of $5.45 and EBITDA guidance of $620 million both missed. Management cited equipment and automation strength and Eddyfi integration, while Middle East revenue fell due to geopolitical disruption and higher logistics costs.

$ESABMedAI 8/10

ESAB Q2 Earnings Call Highlights

ESAB (NYSE:ESAB) discussed its Q2 earnings call and Eddyfi integration. Management said Eddyfi has high-single-digit growth, ~65% gross margins and ~30% EBITDA margins, with a ~$450 million commercial funnel. ESAB raised FY2026 outlook to core sales of ~$3.0-3.1B, adjusted EPS $5.40-5.50, and adjusted EBITDA $615-625M.

$ESABHigh

ESAB Corp (ESAB): Results of Operations and Financial Condition

ESAB Corp (ESAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. ESAB Corporation Announces Second Quarter 2026 Results • Record total sales increased 12.9%, with core organic sales up 2.5% • Core organic growth in both segments • Closed Eddyfi ahead of schedule • Updating 2026 outlook North Bethesda, MD, August 6, 2026 -- ESAB Corporation (“E

$ESABMed

Q4 Results 29th May Live: Asian Paints, IndiGo, NMDC, Glenmark Pharma, Ipca Lab, IREDA, Gujarat Gas, Natco Pharma, Inox Wind, Rubicon Research, BEML, NMDC Steel, JM Financial, Triveni Engg to announce

The article previews Q4 results from multiple Indian companies and highlights several earnings updates. Prime Focus reported standalone net profit of Rs 4.32 crore for March 2026 quarter vs Rs 16.11 crore loss a year earlier. Alkem Laboratories’ standalone net profit fell to Rs 217 crore from Rs 276.9 crore; it recommended a final dividend of Rs 10/share. It also cites Q4FY26 figures for ESAB India, Ecos Mobility, and Ivalue Infosolutions, plus early stock moves.